TWiV 831: COVID-19 clinical update #89 with Dr. Daniel Griffin

In COVID-19 clinical update #89, Dr. Griffin reviews upcoming meeting on FDA emergency use authorization for molnupiravir, 25% of US cases in children, reinfection associates with presence of antibodies, national surveillance for acute flaccid myelitis in the US, and monoclonal antibody treatment of infection in vaccinated, high-risk individuals.

Click arrow to play
Download TWiV 831 (20 MB .mp3, 33 min)
Subscribe (free): iTunesGoogle PodcastsRSSemail

Show notes at

Scroll to Top